US Patent Issued to Emory University on July 28 for "Morpholine-containing and piperazine-containing CXCR4 modulators and uses related thereto" (Georgia Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,259, issued on July 28, was assigned to Emory University (Atlanta).

"Morpholine-containing and piperazine-containing CXCR4 modulators and uses related thereto" was invented by Dennis C. Liotta (Atlanta), Edgars Jecs (Atlanta), Yesim Altas Tahirovic (Atlanta), Eric Miller (Atlanta) and Lawrence Wilson (Atlanta).

According to the abstract* released by the U.S. Patent & Trademark Office: "CXCR4 antagonists and pharmaceutical formulations thereof are disclosed. The compounds and pharmaceutical formulations disclosed herein can be used to antagonize the CXCR4 pathway for mobilizing stem cells or treating a condition, disorder, or disease associated with the CXCR4 pathway. Exemplary co...